146 related articles for article (PubMed ID: 17186840)
21. Massive gastric hemorrhage induced by buffered aspirin in a greyhound.
Shaw N; Burrows CF; King RR
J Am Anim Hosp Assoc; 1997; 33(3):215-9. PubMed ID: 9138231
[TBL] [Abstract][Full Text] [Related]
22. In vivo effects of carprofen, deracoxib, and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis.
Sessions JK; Reynolds LR; Budsberg SC
Am J Vet Res; 2005 May; 66(5):812-7. PubMed ID: 15934608
[TBL] [Abstract][Full Text] [Related]
23. Clinical, clinicopathologic, and gastrointestinal changes from aspirin, prednisone, or combination treatment in healthy research dogs: A double-blind randomized trial.
Whittemore JC; Mooney AP; Price JM; Thomason J
J Vet Intern Med; 2019 Sep; 33(5):1977-1987. PubMed ID: 31397009
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic evaluation of the gastroduodenal mucosa to determine the safety of short-term concurrent administration of meloxicam and dexamethasone in healthy dogs.
Boston SE; Moens NM; Kruth SA; Southorn EP
Am J Vet Res; 2003 Nov; 64(11):1369-75. PubMed ID: 14620772
[TBL] [Abstract][Full Text] [Related]
25. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.
Graham DY; Malaty HM; Goodgame R
Am J Gastroenterol; 1997 Aug; 92(8):1322-5. PubMed ID: 9260798
[TBL] [Abstract][Full Text] [Related]
26. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
Lanza FL; Kochman RL; Geis GS; Rack EM; Deysach LG
Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619
[TBL] [Abstract][Full Text] [Related]
27. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
[TBL] [Abstract][Full Text] [Related]
28. Randomised controlled clinical trial for the use of deracoxib during intense rehabilitation exercises after tibial plateau levelling osteotomy.
Gordon-Evans WJ; Dunning D; Johnson AL; Knap KE
Vet Comp Orthop Traumatol; 2010; 23(5):332-5. PubMed ID: 20740263
[TBL] [Abstract][Full Text] [Related]
29. Systematic review of nonsteroidal anti-inflammatory drug-induced adverse effects in dogs.
Monteiro-Steagall BP; Steagall PV; Lascelles BD
J Vet Intern Med; 2013; 27(5):1011-9. PubMed ID: 23782347
[TBL] [Abstract][Full Text] [Related]
30. The effect of 15(R)-15-methyl prostaglandin E2 (Arbacet) on the healing of aspirin or nonsteroidal antiinflammatory drug-induced gastric mucosal lesions: an endoscopic study.
Jaszewski R; Crane SA
Am J Gastroenterol; 1987 Dec; 82(12):1271-4. PubMed ID: 3318402
[TBL] [Abstract][Full Text] [Related]
31. A randomized, placebo-controlled study of the effects of naproxen, aspirin, celecoxib or clopidogrel on gastroduodenal mucosal healing.
Dikman A; Sanyal S; VON Althann C; Whitson M; Desai J; Bodian C; Brooks A; Bamji N; Cohen L; Miller K; Aisenberg J
Aliment Pharmacol Ther; 2009 Apr; 29(7):781-91. PubMed ID: 19183162
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the effects of deracoxib and piroxicam on the in vitro viability of osteosarcoma cells from dogs.
Royals SR; Farese JP; Milner RJ; Lee-Ambrose L; van Gilder J
Am J Vet Res; 2005 Nov; 66(11):1961-7. PubMed ID: 16334957
[TBL] [Abstract][Full Text] [Related]
33. Effect of deracoxib, a new COX-2 inhibitor, on the prevention of lameness induced by chemical synovitis in dogs.
Millis DL; Weigel JP; Moyers T; Buonomo FC
Vet Ther; 2002; 3(4):453-64. PubMed ID: 12584683
[TBL] [Abstract][Full Text] [Related]
34. The use of a synthetic prostaglandin E1 analog as a gastric protectant against aspirin-induced hemorrhage in the dog.
Bowersox TS; Lipowitz AJ; Hardy RM; Johnston GR; Hayden DW; Schwartz S; King VL
J Am Anim Hosp Assoc; 1996; 32(5):401-7. PubMed ID: 8875355
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogs.
Rau SE; Barber LG; Burgess KE
J Vet Intern Med; 2010; 24(6):1452-7. PubMed ID: 21039869
[TBL] [Abstract][Full Text] [Related]
36. Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder.
McMillan SK; Boria P; Moore GE; Widmer WR; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2011 Oct; 239(8):1084-9. PubMed ID: 21985349
[TBL] [Abstract][Full Text] [Related]
37. Gastroscopic Study of Meloxicam, Tramadol, and Their Combined Administration on the Development of Gastric Injuries in Dogs.
Eskafian H; Shojaee Tabrizi A; Ansari Lari M
Top Companion Anim Med; 2017 Sep; 32(3):109-113. PubMed ID: 29291772
[TBL] [Abstract][Full Text] [Related]
38. Serum salicylate concentrations and endoscopic evaluation of the gastric mucosa in dogs after oral administration of aspirin-containing products.
Lipowitz AJ; Boulay JP; Klausner JS
Am J Vet Res; 1986 Jul; 47(7):1586-9. PubMed ID: 3740630
[TBL] [Abstract][Full Text] [Related]
39. Gastroscopic evaluation of the effect of aspirin and oxaprozin on the gastric mucosa.
Lanza FL; Hubsher JA; Walker BR
J Clin Pharmacol; 1981 Apr; 21(4):157-61. PubMed ID: 7240437
[TBL] [Abstract][Full Text] [Related]
40. The effect of misoprostol on aspirin-induced gastroduodenal lesions in dogs.
Johnston SA; Leib MS; Forrester SD; Marini M
J Vet Intern Med; 1995; 9(1):32-8. PubMed ID: 7891360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
